Corrigendum to “Sn38 Conjugated Hyaluronic Acid Gold Nanoparticles As a Novel System Against Metastatic Colon Cancer Cells” [Int. J. Pharm. 526(1–2) (2017) 339–352, (S037851731730371x), (10.1016/J.Ijpharm.2017.04.060)]

Corrigendum to “Sn38 Conjugated Hyaluronic Acid Gold Nanoparticles As a Novel System Against Metastatic Colon Cancer Cells” [Int. J. Pharm. 526(1–2) (2017) 339–352, (S037851731730371x), (10.1016/J.Ijpharm.2017.04.060)] Publisher Pubmed

Hosseinzadeh H^{1, 2} ; Atyabi F^{1, 3} ; Varnamkhasti BS² ; Hosseinzadeh R⁴ ; Ostad SN^{1, 5} ; Ghahremani MH^{1, 5} ; Dinarvand R^{1, 2, 3}

Show Affiliations

1. Nanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 1417614411, Iran
2. Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
3. Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
4. Medical Laser Research Center, ACECR, Tehran, Iran
5. Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Source: International Journal of Pharmaceutics Published:2022

Abstract

The authors regret to report about an inadvertent mistake happened to Fig. 9 of this paper. The control panel showing HT29 cells on the surface of the pellet at time zero was mistakenly the mirror image of the same for MUC1 modified SN38-HA-Au NPs treated cells at the same time zero. We corrected this inadvertent error and provide the correct Fig. 9 here: The authors would like to apologise for any inconvenience caused. © 2022

Style	Citing Format
MLA	Hosseinzadeh H, et al.. "Corrigendum to “Sn38 Conjugated Hyaluronic Acid Gold Nanoparticles As a Novel System Against Metastatic Colon Cancer Cells” [Int. J. Pharm. 526(1–2) (2017) 339–352, (S037851731730371x), (10.1016/J.Ijpharm.2017.04.060)]." International Journal of Pharmaceutics, vol. 626, no. , 2022, pp. -.
APA	Hosseinzadeh H, Atyabi F, Varnamkhasti BS, Hosseinzadeh R, Ostad SN, Ghahremani MH, Dinarvand R (2022). Corrigendum to “Sn38 Conjugated Hyaluronic Acid Gold Nanoparticles As a Novel System Against Metastatic Colon Cancer Cells” [Int. J. Pharm. 526(1–2) (2017) 339–352, (S037851731730371x), (10.1016/J.Ijpharm.2017.04.060)]. International Journal of Pharmaceutics, 626(), -.
Chicago	Hosseinzadeh H, Atyabi F, Varnamkhasti BS, Hosseinzadeh R, Ostad SN, Ghahremani MH, Dinarvand R. "Corrigendum to “Sn38 Conjugated Hyaluronic Acid Gold Nanoparticles As a Novel System Against Metastatic Colon Cancer Cells” [Int. J. Pharm. 526(1–2) (2017) 339–352, (S037851731730371x), (10.1016/J.Ijpharm.2017.04.060)]." International Journal of Pharmaceutics 626, no. (2022): -.
Harvard	Hosseinzadeh H et al. (2022) 'Corrigendum to “Sn38 Conjugated Hyaluronic Acid Gold Nanoparticles As a Novel System Against Metastatic Colon Cancer Cells” [Int. J. Pharm. 526(1–2) (2017) 339–352, (S037851731730371x), (10.1016/J.Ijpharm.2017.04.060)]', International Journal of Pharmaceutics, 626(), pp. -.
Vancouver	Hosseinzadeh H, Atyabi F, Varnamkhasti BS, Hosseinzadeh R, Ostad SN, Ghahremani MH, et al.. Corrigendum to “Sn38 Conjugated Hyaluronic Acid Gold Nanoparticles As a Novel System Against Metastatic Colon Cancer Cells” [Int. J. Pharm. 526(1–2) (2017) 339–352, (S037851731730371x), (10.1016/J.Ijpharm.2017.04.060)]. International Journal of Pharmaceutics. 2022;626():-.
BibTex	@article{ author = {Hosseinzadeh H and Atyabi F and Varnamkhasti BS and Hosseinzadeh R and Ostad SN and Ghahremani MH and Dinarvand R}, title = {Corrigendum to “Sn38 Conjugated Hyaluronic Acid Gold Nanoparticles As a Novel System Against Metastatic Colon Cancer Cells” [Int. J. Pharm. 526(1–2) (2017) 339–352, (S037851731730371x), (10.1016/J.Ijpharm.2017.04.060)]}, journal = {International Journal of Pharmaceutics}, volume = {626}, number = {}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Hosseinzadeh H AU - Atyabi F AU - Varnamkhasti BS AU - Hosseinzadeh R AU - Ostad SN AU - Ghahremani MH AU - Dinarvand R TI - Corrigendum to “Sn38 Conjugated Hyaluronic Acid Gold Nanoparticles As a Novel System Against Metastatic Colon Cancer Cells” [Int. J. Pharm. 526(1–2) (2017) 339–352, (S037851731730371x), (10.1016/J.Ijpharm.2017.04.060)] JO - International Journal of Pharmaceutics VL - 626 IS - SP - EP - PY - 2022 ER -

Style

Citing Format

MLA

Hosseinzadeh H, et al.. "Corrigendum to “Sn38 Conjugated Hyaluronic Acid Gold Nanoparticles As a Novel System Against Metastatic Colon Cancer Cells” [Int. J. Pharm. 526(1–2) (2017) 339–352, (S037851731730371x), (10.1016/J.Ijpharm.2017.04.060)]." International Journal of Pharmaceutics, vol. 626, no. , 2022, pp. -.

APA

Hosseinzadeh H, Atyabi F, Varnamkhasti BS, Hosseinzadeh R, Ostad SN, Ghahremani MH, Dinarvand R (2022). Corrigendum to “Sn38 Conjugated Hyaluronic Acid Gold Nanoparticles As a Novel System Against Metastatic Colon Cancer Cells” [Int. J. Pharm. 526(1–2) (2017) 339–352, (S037851731730371x), (10.1016/J.Ijpharm.2017.04.060)]. International Journal of Pharmaceutics, 626(), -.

Chicago

Hosseinzadeh H, Atyabi F, Varnamkhasti BS, Hosseinzadeh R, Ostad SN, Ghahremani MH, Dinarvand R. "Corrigendum to “Sn38 Conjugated Hyaluronic Acid Gold Nanoparticles As a Novel System Against Metastatic Colon Cancer Cells” [Int. J. Pharm. 526(1–2) (2017) 339–352, (S037851731730371x), (10.1016/J.Ijpharm.2017.04.060)]." International Journal of Pharmaceutics 626, no. (2022): -.

Harvard

Hosseinzadeh H et al. (2022) 'Corrigendum to “Sn38 Conjugated Hyaluronic Acid Gold Nanoparticles As a Novel System Against Metastatic Colon Cancer Cells” [Int. J. Pharm. 526(1–2) (2017) 339–352, (S037851731730371x), (10.1016/J.Ijpharm.2017.04.060)]', International Journal of Pharmaceutics, 626(), pp. -.

Vancouver

Hosseinzadeh H, Atyabi F, Varnamkhasti BS, Hosseinzadeh R, Ostad SN, Ghahremani MH, et al.. Corrigendum to “Sn38 Conjugated Hyaluronic Acid Gold Nanoparticles As a Novel System Against Metastatic Colon Cancer Cells” [Int. J. Pharm. 526(1–2) (2017) 339–352, (S037851731730371x), (10.1016/J.Ijpharm.2017.04.060)]. International Journal of Pharmaceutics. 2022;626():-.

BibTex

@article{ author = {Hosseinzadeh H and Atyabi F and Varnamkhasti BS and Hosseinzadeh R and Ostad SN and Ghahremani MH and Dinarvand R}, title = {Corrigendum to “Sn38 Conjugated Hyaluronic Acid Gold Nanoparticles As a Novel System Against Metastatic Colon Cancer Cells” [Int. J. Pharm. 526(1–2) (2017) 339–352, (S037851731730371x), (10.1016/J.Ijpharm.2017.04.060)]}, journal = {International Journal of Pharmaceutics}, volume = {626}, number = {}, pages = {-}, year = {2022} }

RIS

TY - JOUR
AU - Hosseinzadeh H
AU - Atyabi F
AU - Varnamkhasti BS
AU - Hosseinzadeh R
AU - Ostad SN
AU - Ghahremani MH
AU - Dinarvand R
TI - Corrigendum to “Sn38 Conjugated Hyaluronic Acid Gold Nanoparticles As a Novel System Against Metastatic Colon Cancer Cells” [Int. J. Pharm. 526(1–2) (2017) 339–352, (S037851731730371x), (10.1016/J.Ijpharm.2017.04.060)]
JO - International Journal of Pharmaceutics
VL - 626
IS -
SP -
EP -
PY - 2022
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract